• 1
    Holle LM. Pegaspargase: an alternative? Ann Pharmacother 1997; 31: 61624.
  • 2
    Sahu S, Saika S, Pai SK, Advani SH. L-asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1998; 15: 5338.
  • 3
    Tan Y, Sun X, Xu M, Tan X, Sasson A, Rashidi B, Han Q, Wang X, An Z, Sun FX, Hoffman RM. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice. Clin Cancer Res 1999; 5: 215763.
  • 4
    Yoshioka T, Wada T, Uchida N, Maki H, Yoshida H, Ide N, Kasai H, Hojo K, Shono K, Maekawa R, Yagi S, Hoffman RM, et al. Anticancer efficacy in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase. Cancer Res 1998; 58: 25837.
  • 5
    Degnan BA, Palmer JM, Robson T, Jones CE, Fischer M, Glanville M, Mellor GD, Diamond AG, Kehoe MA, Goodacre JA. Inhibition of human peripheral blood mononuclear cell proliferation by Streptococcus pyogenes cell extract is associated with arginine deiminase activity. Infect Immunol 1998; 66: 30508.
  • 6
    Knodler LA, Schofield PJ, Gooley AA, Edwards MR. Giardia intestinalis: purification and partial amino acid sequence of arginine deiminase. Exp Parasitol 1997; 85: 7780.
  • 7
    Komada Y, Zhang XL, Zhou YW, Ido M, Azuma E. Apoptotic cell death of human T lymphoblastoid cells induced by arginine deiminase. Int J Hematol 1997; 65: 12941.
  • 8
    Ensor CM, Holtsberg FW, Bomalaski JS, Clark MA. Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo. Cancer Res 2002; 62: 544350.
  • 9
    Gong H, Zolzer F, von Recklinghausen G, Rossler J, Breit S, Havers W, Fotsis T, Schweigerer L. Arginine deiminase inhibits cell proliferation by arresting cell cycle and inducing apoptosis. Biochem Biophys Res Commun 1999; 261: 104.
  • 10
    Takaku H, Takase M, Abe S, Hayashi H, Miyazaki K. In vivo anti-tumor activity of arginine deiminase purified from Mycoplasma arginini. Int J Cancer 1992; 51: 2449.
  • 11
    Park IS, Kang SW, Shin YJ, Chae KY, Park MO, Kim MY, Wheatley DN, Min BH. Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth. Br J Cancer 2003; 89: 90714.
  • 12
    Gong H, Pottgen C, Stuben G, Havers W, Stuschke M, Schweigerer L. Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: potentiation by irradiation. Int J Cancer 2003; 106: 7238.
  • 13
    Beloussow K, Wang L, Wu J, Ann D, Shen WC. Recombinant arginine deiminase as a potential anti-angiogenic agent. Cancer Lett 2002; 183: 15562.
  • 14
    Esch F, Lin KI, Hills A, Zaman K, Baraban JM, Chatterjee S, Rubin L, Ash DE, Ratan RR. Purification of a multipotent antideath activity from bovine liver and its identification as arginase: nitric oxide-independent inhibition of neuronal apoptosis. J Neurosci 1998; 18: 408395.
  • 15
    Kang SW, Kang H, Park IS, Choi SH, Shin KH, Chun YS, Chun BG, Min BH. Cytoprotective effect of arginine deiminase on taxol-induced apoptosis in DU145 human prostate cancer cells. Mol Cells 2000; 10: 3317.
  • 16
    Pae HO, Yoo JC, Choi BM, Kang CL, Kim JD, Chung HT. Apoptotic cell death induced by taxol is inhibited by nitric oxide in human leukemia HL-60 cells. Immunopharmacol Immunotoxicol 1999; 21: 66782.
  • 17
    Harmon JM, Norman MR, Fowlkes BJ, Thompson EB. Dexamethasone induces irreversible G1 arrest and death of a human lymphoid cell line. J Cell Physiol 1979; 98: 26778.
  • 18
    Thompson EB, Medh RD, Zhou F, Ayala-Torres S, Ansari N, Zhang W, Johnson BH. Glucocorticoids, oxysterols, and cAMP with glucocorticoids each cause apoptosis of CEM cells and suppress c-myc. J Steroid Biochem Mol Biol 1999; 69: 45361.
  • 19
    Noh EJ, Kang SW, Shin YJ, Kim DC, Park IS, Kim MY, Chun BG, Min BH. Characterization of mycoplasma arginine deiminase expressed in E. coli and its inhibitory regulation of nitric oxide synthesis. Mol Cells 2002; 13: 13743.
  • 20
    Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 1569.
  • 21
    Miyazaki K, Takaku H, Umeda M, Fujita T, Huang WD, Kimura T, Yamashita J, Horio T. Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a Mycoplasma-infected cell line. Cancer Res 1990; 50: 45227.
  • 22
    Wheatley DN, Scott L, Lamb J, Smith S. Single amino acid (arginine) restriction: growth and death of cultured HeLa and human diploid fibroblasts. Cell Physiol Biochem 2000; 10: 3755.
  • 23
    Rabinovitz M. The pleiotypic response to amino acid deprivation is the result of interactions between components of the glycolysis and protein synthesis pathways. FEBS Lett 1992; 302: 1136.
  • 24
    Scott L, Lamb J, Smith S, Wheatley DN. Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells. Br J Cancer 2000; 83: 80010.
  • 25
    Shen LJ, Lin WC, Beloussow K, Shen WC. Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase. Cancer Lett 2003; 191: 16570.
  • 26
    Wu G, Morris SM, Jr. Arginine metabolism: nitric oxide and beyond. Biochem J 1998; 336: 117.
  • 27
    Pegg AE. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res 1988; 48: 75974.
  • 28
    Choi SH, Kim SW, Choi DH, Min BH, Chun BG. Polyamine-depletion induces p27Kip1 and enhances dexamethasone-induced G1 arrest and apoptosis in human T lymphoblastic leukemia cells. Leuk Res 2000; 24: 11927.
  • 29
    Miller AL, Johnson BH, Medh RD, Townsend CM, Thompson EB. Glucocorticoids and polyamine inhibitors synergize to kill human leukemic CEM cells. Neoplasia 2002; 4: 6881.
  • 30
    Yuh YS, Thompson EB. Glucocorticoid effect on oncogene/growth gene expression in human T lymphoblastic leukemic cell line CCRF-CEM. Specific c-myc mRNA suppression by dexamethasone. J Biol Chem 1989; 264: 1090410.
  • 31
    Thulasi R, Harbour DV, Thompson EB. Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis. J Biol Chem 1993; 268: 1830612.
  • 32
    Medh RD, Saeed MF, Johnson BH, Thompson EB. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression. Cancer Res 1998; 58: 368493.
  • 33
    Oster SK, Ho CS, Soucie EL, Penn LZ. The myc oncogene: MarvelouslY Complex. Adv Cancer Res 2002; 84: 81154.